Pulsion Medical Systems SE (LTS:0NFX) 3-Year EBITDA Growth Rate : 16.10% (As of Dec. 2022)

View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE 3-Year EBITDA Growth Rate?

Pulsion Medical Systems SE's EBITDA per Share for the six months ended in Dec. 2022 was €0.90.

During the past 12 months, Pulsion Medical Systems SE's average EBITDA Per Share Growth Rate was 20.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pulsion Medical Systems SE was 215.60% per year. The lowest was -44.20% per year. And the median was 5.90% per year.

Competitive Comparison of Pulsion Medical Systems SE's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Pulsion Medical Systems SE's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pulsion Medical Systems SE's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pulsion Medical Systems SE's 3-Year EBITDA Growth Rate falls into.

Pulsion Medical Systems SE 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Pulsion Medical Systems SE (LTS:0NFX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Pulsion Medical Systems SE 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulsion Medical Systems SE (LTS:0NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hans-Riedl-Street 17, Feldkirchen, DEU, 85622

Website

http://www.pulsion.com

Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE (LTS:0NFX) Headlines

No Headlines